Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2006-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24559d49180ce106c7652315d908b67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7df901482d108dadb95f5abe683c793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bded9e474eae69e216e6e5d3d92f8e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff45233e3eb3a0132ca8b8d37bc05834 |
publicationDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2369046-T3 |
titleOfInvention |
USE OF A DPP-IV INHIBITOR TO REDUCE HYPOGLUCEMIC EVENTS. |
abstract |
Use of a DPP-IV inhibitor or a salt thereof for the manufacture of a medicament for the reduction of hypoglycemic events or severe hypoglycemic events, in patients being treated with insulin, in which the DPP-IV inhibitor is vildagliptin or a Get out of it. |
priorityDate |
2005-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |